3billion, Inc. (KOSDAQ:394800)

South Korea · Delayed Price · Currency is KRW

12,810

-280 (-2.14%)

At close: Apr 28, 2026

91.19% (1Y)

Market Cap	406.86B
Revenue (ttm)	11.71B
Net Income (ttm)	-5.41B
Shares Out	31.76M
EPS (ttm)	-171.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	290,427
Average Volume	238,367
Open	13,280
Previous Close	13,090
Day's Range	12,700 - 13,320
52-Week Range	5,520 - 20,100
Beta	n/a
RSI	50.74
Earnings Date	Mar 27, 2026

About 3billion

3billion, Inc. develops technology for rare disease drug discovery using bioinformatics and machine learning technology. The company focuses on developing methods for novel drug target discovery, drug candidate generation, and safety assessment. It offers genetic and biomolecular testing services related to the analysis of biologic samples of patients suspected to have rare genetic disorders, as well as provides various affiliated services to customers. The company was founded in 2016 and is based in Seoul, South Korea. [Read more]

Industry In Vitro and In Vivo Diagnostic Substances

Founded 2016

Country South Korea

Stock Exchange KOSDAQ

Ticker Symbol 394800

Full Company Profile

Financial Performance

In 2025, 3billion's revenue was 11.71 billion, an increase of 102.85% compared to the previous year's 5.77 billion. Losses were -5.41 billion, -17.66% less than in 2024.

Financial Statements

News

There is no news available yet.